Iceman, thanks for the questions.....
Figure to get this to market, I believe the company will have to spend another $150-200 million US. I figure that the company could potentially be selling their TAVR in EU or US around 3-4 years from now and to get there I believe $50 million US a year, trials, admin, r&d etc....
My own figure for a buyout is $15 Billion US or approximately 1x what I believe the TAVR market will be worth 6-7 years from now. My own figure for a buyout USED to be considerably lower BUT..... BUT..... the more I hear the experts talk the more I believe that AVR's DurAVR will own and dominate the TAVR market COMPLETELY.... it will basically act as a monopoly.
So whoever buys it will own the $12 Billion US by 2025 market and be able to sell at very high margins making massive profits.
As well as that the company who buys AVR will be able to leverage their ADAPT technology to then go onto create numerous other products...
Just my own thoughts, could be very wrong, although that's the way I see it currently.
- Forums
- ASX - By Stock
- AVR
- AVR CMO Dr Chris Meduri discusses DurAVR with Dr Bapat
AVR
anteris technologies global corp.
Add to My Watchlist
6.09%
!
$6.27

AVR CMO Dr Chris Meduri discusses DurAVR with Dr Bapat, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.27 |
Change
0.360(6.09%) |
Mkt cap ! $97.17M |
Open | High | Low | Value | Volume |
$5.93 | $6.30 | $5.91 | $107.9K | 17.39K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | $6.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.27 | 200 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | 6.120 |
1 | 2000 | 6.100 |
1 | 1000 | 6.000 |
1 | 1250 | 5.950 |
1 | 857 | 5.830 |
Price($) | Vol. | No. |
---|---|---|
6.270 | 200 | 1 |
6.300 | 463 | 1 |
6.400 | 130 | 1 |
6.500 | 255 | 1 |
6.550 | 1092 | 1 |
Last trade - 15.42pm 27/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online